News: ‘A Game Changer’: Drug Brings Weight... (The New York Times) - Behind the headlines
In the news
Media coverage of health and science topics
‘A Game Changer’: Drug Brings Weight Loss in Patients With Obesity (Published 2021)
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
Read more at The New York Times
Behind the headlines
Research findings and data from the National Library of Medicine
PubMed articles
Once-Weekly Semaglutide in Adults with Overweight or Obesity
In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in …
Related content
Similar articles
People also viewed
Also of interest
Additional recent and related news
Weight-loss drugs are a milestone for the obese but expose health inequity
The new medications, developed for diabetes but highly effective for obesity, are far superior to older weight-loss drugs.
New Drugs Could Help Treat Obesity. Could They End the Stigma, Too? (Published 2021)
The hope is that new treatments will encourage people to think of obesity as a chronic disease, like high blood pressure or diabetes.
Patients grapple with side effects of popular weight-loss drugs
The medications help people lose significant weight but can cause nausea and other complications.
How promising are new drugs to treat obesity and who should — and shouldn't — use them? Our medical analyst explains | CNN
How do the diabetes drugs semaglutide and tirzepatide work to reduce obesity? How promising are they to treat obesity? What are their side effects? Who is eligible to take them? CNN Medical Analyst Dr. Leana Wen answers these questions.
Weight loss drug reverses obesity for nearly half of teens in study
Semaglutide was recently approved by the FDA to help obese adolescents lose weight. When used to treat diabetes, the drug is sold under the brand name Ozempic.